The Connecticut Cardiovascular Consortium: a unique, state-wide research collaboration to advance clinical outcomes in patients with heart disease.
The establishment of "best clinical practices" founded upon evidence-based medicine has become an increasingly important priority. Frequently, management guidelines are derived from published research data and disseminated among practitioners to help optimize patient care. The ultimate clinical impact of these guidelines in the "real world," however, is often clouded by an incomplete assessment of patient outcomes throughout the continuum of health-care delivery models. In order to address this gap in clinical outcome assessment, we propose to establish the Connecticut Cardiovascular Consortium. The Consortium will consist of a collaborative partnership among all 31 Connecticut hospitals working in concert with Connecticut Office of Health Care Access (OHCA). The primary objective of the Consortium will be to assess, compare, and optimize clinical outcomes among Connecticut residents with cardiovascular disease. As an initial goal for the Consortium, we further propose to undertake a prospective, observational study of Connecticut residents who present with ST Segment Elevation Acute Myocardial Infarction (STEMI). Recent advances in pharmacologic and mechanical reperfusion for STEMI have resulted in a need to define the optimal use of these therapies in the community at large. The primary purpose of this study will be to determine the relative merits of different treatment patterns for STEMI with regard to the use of fibrinolytic therapy and percutaneous coronary intervention (PCI). Particular emphasis will be placed on assessing the relative benefits of urgent mechanical revascularization performed at the state's seven tertiary facilities with PCI capability compared to all other treatment modalities. Successful completion of this unique collaborative endeavor is expected to have significant impact on improved patient care and on current health-care policy for medical resource allocation. Moreover, continued collaboration of health-care providers within the Connecticut Cardiovascular Consortium infrastructure should serve as a useful mechanism for ongoing improvements in evidence-based cardiovascular medicine and clinical research in the state of Connecticut.
Boden
W E
WE
Hartford Hospital, Hartford, USA.
McKay
R G
RG
Cabin
H S
HS
Radford
M J
MJ
Krumholz
H M
HM
Zaret
B L
BL
Garner
L
L
Bull
M B
MB
Fisherkeller
M
M
Kosinski
E J
EJ
Krauthamer
M J
MJ
Maljanian
R
R
McDowell
A V
AV
Sands
M J
MJ
Schwartz
K V
KV
Seltzer
J P
JP
Hager
J D
JD
D003237:Connecticut; D019317:Evidence-Based Medicine; D006331:Heart Diseases / Q000628:therapy*; D006801:Humans; D009203:Myocardial Infarction / Q000628:therapy; D017063:Outcome Assessment, Health Care; D012106:Research